Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma

Sixia Huang(Peking University), Ting Li(Nankai University), Bo Zhang(Nanchang Center for Disease Control and Prevention), Wei Wang(The University of Texas MD Anderson Cancer Center), Dong Li(Peking University), Liang Li(Peking University), Lin Nong(Peking University), Jumei Liu(Xiamen University), Xin Li(Peking University), Yalin Zheng(University of Liverpool)
Diagnostic Pathology
July 17, 2019
10.1186/s13000-019-0856-7
Cited by 46

Related Papers

Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
|Nature Genetics|2011|230
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
|Blood|2016|191
Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance
|Journal of Cancer|2014|61
Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.
|PubMed|2015|54
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma
|Modern Pathology|2017|53